iodixanol has been researched along with Hepatitis C in 1 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vercauteren, K | 1 |
Van Den Eede, N | 1 |
Mesalam, AA | 1 |
Belouzard, S | 1 |
Catanese, MT | 1 |
Bankwitz, D | 1 |
Wong-Staal, F | 1 |
Cortese, R | 1 |
Dubuisson, J | 1 |
Rice, CM | 1 |
Pietschmann, T | 1 |
Leroux-Roels, G | 1 |
Nicosia, A | 1 |
Meuleman, P | 1 |
1 other study available for iodixanol and Hepatitis C
Article | Year |
---|---|
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Hepacivirus; Hepatitis C; Humans; Lipoproteins; M | 2014 |